57 results
Page 2 of 3
8-K
EX-99.2
uvxt nrgd
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
S-8
EX-99.1
n4enhc6w9r4h doinil3
9 Aug 21
Registration of securities for employees
12:00am
S-3ASR
EX-1.2
pm6sp 54j2q
2 Apr 21
Automatic shelf registration
4:59pm
S-3ASR
EX-4.4
g3zoj
2 Apr 21
Automatic shelf registration
4:59pm
8-K
EX-1.1
6x5nih gi54vdwx
9 Dec 20
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-99.2
xom dltgk8a
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-1.1
253zz3
12 May 20
Entry into a Material Definitive Agreement
5:14pm